Main	O
Outcomes	O
and	O
Measures	O
The	O
primary	O
end	O
point	O
was	O
clinical	B-PrimaryOutcome
status	I-PrimaryOutcome
on	B-TimeFrame
day	I-TimeFrame
11	I-TimeFrame
on	B-OutcomeDefinition
a	I-OutcomeDefinition
7	I-OutcomeDefinition
-	I-OutcomeDefinition
point	I-OutcomeDefinition
ordinal	I-OutcomeDefinition
scale	I-OutcomeDefinition
ranging	I-OutcomeDefinition
from	I-OutcomeDefinition
death	I-OutcomeDefinition
(	I-OutcomeDefinition
category	I-OutcomeDefinition
1	I-OutcomeDefinition
)	I-OutcomeDefinition
to	I-OutcomeDefinition
discharged	I-OutcomeDefinition
(	I-OutcomeDefinition
category	I-OutcomeDefinition
7	I-OutcomeDefinition
)	I-OutcomeDefinition
.	O

Differences	O
between	O
remdesivir	O
treatment	O
groups	O
and	O
standard	O
care	O
were	O
calculated	O
using	O
proportional	O
odds	O
models	O
and	O
expressed	O
as	O
odds	O
ratios	O
.	O

An	O
odds	O
ratio	O
greater	O
than	O
1	O
indicates	O
difference	O
in	O
clinical	O
status	O
distribution	O
toward	O
category	O
7	O
for	O
the	O
remdesivir	O
group	O
vs	O
the	O
standard	O
care	O
group	O
.	O

End	O
Points	O

The	O
primary	O
efficacy	O
end	O
point	O
was	O
the	O
distribution	B-PrimaryOutcome
of	I-PrimaryOutcome
clinical	I-PrimaryOutcome
status	I-PrimaryOutcome
assessed	I-PrimaryOutcome
on	I-PrimaryOutcome
the	I-PrimaryOutcome
7	I-PrimaryOutcome
-	I-PrimaryOutcome
point	I-PrimaryOutcome
ordinal	I-PrimaryOutcome
scale	I-PrimaryOutcome
on	B-TimeFrame
study	I-TimeFrame
day	I-TimeFrame
11	I-TimeFrame
.	O

If	O
remdesivir	O
treatment	O
improves	O
outcomes	O
,	O
the	O
distribution	O
of	O
scores	O
among	O
patients	O
who	O
received	O
remdesivir	O
should	O
shift	O
more	O
toward	O
the	O
higher	O
values	O
of	O
the	O
scale	O
than	O
the	O
distribution	O
of	O
scores	O
among	O
patients	O
who	O
received	O
standard	O
care	O
.	O

The	O
secondary	O
end	O
point	O
was	O
the	O
proportion	B-SecondaryOutcome
of	I-SecondaryOutcome
patients	I-SecondaryOutcome
with	I-SecondaryOutcome
adverse	I-SecondaryOutcome
events	I-SecondaryOutcome
throughout	B-TimeFrame
the	I-TimeFrame
duration	I-TimeFrame
of	I-TimeFrame
the	I-TimeFrame
study	I-TimeFrame
.	O

Prespecified	O
exploratory	O
end	O
points	O
were	O
(	O
1	O
)	O
time	B-OtherOutcome
to	I-OtherOutcome
recovery	I-OtherOutcome
(	O
improvement	B-OutcomeDefinition
from	I-OutcomeDefinition
a	I-OutcomeDefinition
baseline	I-OutcomeDefinition
score	I-OutcomeDefinition
of	I-OutcomeDefinition
2	I-OutcomeDefinition
-	I-OutcomeDefinition
5	I-OutcomeDefinition
to	I-OutcomeDefinition
a	I-OutcomeDefinition
score	I-OutcomeDefinition
of	I-OutcomeDefinition
6	I-OutcomeDefinition
or	I-OutcomeDefinition
7	I-OutcomeDefinition
or	I-OutcomeDefinition
from	I-OutcomeDefinition
a	I-OutcomeDefinition
baseline	I-OutcomeDefinition
score	I-OutcomeDefinition
of	I-OutcomeDefinition
6	I-OutcomeDefinition
to	I-OutcomeDefinition
a	I-OutcomeDefinition
score	I-OutcomeDefinition
of	I-OutcomeDefinition
7	I-OutcomeDefinition
)	O
;	O
(	O
2	O
)	O
time	B-OtherOutcome
to	I-OtherOutcome
modified	I-OtherOutcome
recovery	I-OtherOutcome
(	O
improvement	B-OutcomeDefinition
from	I-OutcomeDefinition
a	I-OutcomeDefinition
baseline	I-OutcomeDefinition
score	I-OutcomeDefinition
of	I-OutcomeDefinition
2	I-OutcomeDefinition
-	I-OutcomeDefinition
4	I-OutcomeDefinition
to	I-OutcomeDefinition
a	I-OutcomeDefinition
score	I-OutcomeDefinition
of	I-OutcomeDefinition
5	I-OutcomeDefinition
-	I-OutcomeDefinition
7	I-OutcomeDefinition
,	I-OutcomeDefinition
improvement	I-OutcomeDefinition
from	I-OutcomeDefinition
a	I-OutcomeDefinition
baseline	I-OutcomeDefinition
score	I-OutcomeDefinition
of	I-OutcomeDefinition
5	I-OutcomeDefinition
to	I-OutcomeDefinition
a	I-OutcomeDefinition
score	I-OutcomeDefinition
of	I-OutcomeDefinition
6	I-OutcomeDefinition
-	I-OutcomeDefinition
7	I-OutcomeDefinition
,	I-OutcomeDefinition
or	I-OutcomeDefinition
improvement	I-OutcomeDefinition
from	I-OutcomeDefinition
a	I-OutcomeDefinition
baseline	I-OutcomeDefinition
score	I-OutcomeDefinition
of	I-OutcomeDefinition
6	I-OutcomeDefinition
to	I-OutcomeDefinition
a	I-OutcomeDefinition
score	I-OutcomeDefinition
of	I-OutcomeDefinition
7	I-OutcomeDefinition
)	O
;	O
(	O
3	O
)	O
time	B-OtherOutcome
to	I-OtherOutcome
clinical	I-OtherOutcome
improvement	I-OtherOutcome
(	B-OutcomeDefinition
â‰¥	I-OutcomeDefinition
2	I-OutcomeDefinition
-	I-OutcomeDefinition
point	I-OutcomeDefinition
improvement	I-OutcomeDefinition
from	I-OutcomeDefinition
baseline	I-OutcomeDefinition
on	I-OutcomeDefinition
the	I-OutcomeDefinition
7	I-OutcomeDefinition
-	I-OutcomeDefinition
point	I-OutcomeDefinition
ordinal	I-OutcomeDefinition
scale	I-OutcomeDefinition
)	O
;	O
(	O
4	O
)	O
time	B-OtherOutcome
to	I-OtherOutcome
1	I-OtherOutcome
-	I-OtherOutcome
point	I-OtherOutcome
or	I-OtherOutcome
larger	I-OtherOutcome
improvement	I-OtherOutcome
;	O
and	O
(	O
5	O
)	O
time	B-OtherOutcome
to	I-OtherOutcome
discontinuation	I-OtherOutcome
of	I-OtherOutcome
any	I-OtherOutcome
oxygen	I-OtherOutcome
support	I-OtherOutcome
.	O

The	O
proportion	O
of	O
patients	O
with	O
these	O
end	O
points	O
was	O
also	O
assessed	O
on	B-TimeFrame
days	I-TimeFrame
5	I-TimeFrame
,	I-TimeFrame
7	I-TimeFrame
,	I-TimeFrame
and	I-TimeFrame
11	I-TimeFrame
.	O

Other	O
exploratory	O
end	O
points	O
were	O
duration	B-OtherOutcome
of	I-OtherOutcome
hospitalization	I-OtherOutcome
,	O
duration	B-OtherOutcome
of	I-OtherOutcome
different	I-OtherOutcome
modes	I-OtherOutcome
of	I-OtherOutcome
respiratory	I-OtherOutcome
support	I-OtherOutcome
,	O
and	O
all	B-OtherOutcome
-	I-OtherOutcome
cause	I-OtherOutcome
mortality	I-OtherOutcome
.	O

Due	O
to	O
logistical	O
issues	O
at	O
the	O
time	O
of	O
study	O
implementation	O
,	O
virological	O
and	O
pharmacokinetic	O
measurements	O
were	O
limited	O
,	O
including	O
SARS	O
-	O
CoV	O
-	O
2	O
polymerase	O
chain	O
reaction	O
tests	O
on	O
day	O
5	O
and	O
day	O
10	O
,	O
and	O
are	O
not	O
presented	O
.	O

